Market Cap 1.95B
Revenue (ttm) 5.90M
Net Income (ttm) -87.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,490.85%
Debt to Equity Ratio 0.26
Volume 166,200
Avg Vol 258,008
Day's Range N/A - N/A
Shares Out 128.00M
Stochastic %K 23%
Beta 2.39
Analysts Strong Sell
Price Target $27.00

Company Profile

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company offers Remestemcel-L that is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease and biologic refractory inflammatory bowel disease,...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9639 6036
Fax: 61 3 9639 6030
Address:
55 Collins Street, Level 38, Melbourne, Australia
Portman62
Portman62 Jul. 31 at 2:44 PM
$MESO woohooo!
0 · Reply
Bossrosswisa
Bossrosswisa Jul. 28 at 2:22 AM
1 · Reply
Portman62
Portman62 Jul. 25 at 1:19 AM
$MESO Invested in MESO 5 years ago, confidently I can say they are an above board company and now reaping benefits of their diligences. 🥳
0 · Reply
Mani86
Mani86 Jul. 24 at 1:37 PM
$MESO 👍
0 · Reply
Spectaculator
Spectaculator Jul. 24 at 11:11 AM
$MESO Public record shows very little institutional ownership of MESO. This is where the real upside can come from!!
1 · Reply
hots
hots Jul. 23 at 3:21 PM
$MESO Gregory George is a legend, I definitely think the increased comms and early release of the Q4 position has his mark all over it. Keep up the great work GG and Mesoblast
1 · Reply
Portman62
Portman62 Jul. 23 at 3:01 PM
$MESO hmm, are we looking at ATH by the end of the year?
0 · Reply
Mani86
Mani86 Jul. 23 at 11:42 AM
$MESO https://insightfinancenews.com/commercial-launch-of-ryoncil/?fbclid=IwY2xjawLtqaxleHRuA2FlbQIxMQBicmlkETFOTW42dm83WURDcU45Y2lNAR6i5Qj2CzmbLvCDWnWB3TWOytvTICiO7xbm_n3IiGAaFBlczM_zvPz9MUygIg_aem_7UbXwqX2v92uAwjCvdYGlw
1 · Reply
Portman62
Portman62 Jul. 22 at 1:21 PM
0 · Reply
History101
History101 Jul. 20 at 7:10 PM
$MESO short interest, per Barron's, 6/30/2025: 2.53MM shares short (down 6% from 6/13/2025) 10.6 days to cover
0 · Reply
Latest News on MESO
Successful Commercial Launch of Ryoncil®

Jul 17, 2025, 8:38 PM EDT - 15 days ago

Successful Commercial Launch of Ryoncil®


Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

Apr 28, 2025, 7:44 PM EDT - 3 months ago

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board


First Three Children to Commence Treatment With Ryoncil®

Mar 30, 2025, 7:39 PM EDT - 4 months ago

First Three Children to Commence Treatment With Ryoncil®


Ryoncil® is Now Available for Purchase in the United States

Mar 26, 2025, 8:19 PM EDT - 4 months ago

Ryoncil® is Now Available for Purchase in the United States


Mesoblast Limited (MESO) Q2 2025 Earnings Call Transcript

Feb 28, 2025, 11:38 AM EST - 5 months ago

Mesoblast Limited (MESO) Q2 2025 Earnings Call Transcript


Mesoblast Financial Results and Corporate Update Webcast

Feb 25, 2025, 6:13 PM EST - 5 months ago

Mesoblast Financial Results and Corporate Update Webcast


Dr. Gregory George MD PhD Joins Mesoblast Board

Feb 23, 2025, 6:33 PM EST - 5 months ago

Dr. Gregory George MD PhD Joins Mesoblast Board


Ryoncil® Commercial Launch Update and Product Pipeline

Jan 30, 2025, 7:11 PM EST - 6 months ago

Ryoncil® Commercial Launch Update and Product Pipeline


Mesoblast to be Added to Nasdaq Biotechnology Index

Dec 18, 2024, 7:30 AM EST - 8 months ago

Mesoblast to be Added to Nasdaq Biotechnology Index


Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript

Aug 28, 2024, 9:04 PM EDT - 1 year ago

Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript


Mesoblast Corporate Presentation at Investor Conference

Jun 2, 2024, 8:23 PM EDT - 1 year ago

Mesoblast Corporate Presentation at Investor Conference


Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript

Feb 29, 2024, 6:07 PM EST - 1 year ago

Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript


Portman62
Portman62 Jul. 31 at 2:44 PM
$MESO woohooo!
0 · Reply
Bossrosswisa
Bossrosswisa Jul. 28 at 2:22 AM
1 · Reply
Portman62
Portman62 Jul. 25 at 1:19 AM
$MESO Invested in MESO 5 years ago, confidently I can say they are an above board company and now reaping benefits of their diligences. 🥳
0 · Reply
Mani86
Mani86 Jul. 24 at 1:37 PM
$MESO 👍
0 · Reply
Spectaculator
Spectaculator Jul. 24 at 11:11 AM
$MESO Public record shows very little institutional ownership of MESO. This is where the real upside can come from!!
1 · Reply
hots
hots Jul. 23 at 3:21 PM
$MESO Gregory George is a legend, I definitely think the increased comms and early release of the Q4 position has his mark all over it. Keep up the great work GG and Mesoblast
1 · Reply
Portman62
Portman62 Jul. 23 at 3:01 PM
$MESO hmm, are we looking at ATH by the end of the year?
0 · Reply
Mani86
Mani86 Jul. 23 at 11:42 AM
$MESO https://insightfinancenews.com/commercial-launch-of-ryoncil/?fbclid=IwY2xjawLtqaxleHRuA2FlbQIxMQBicmlkETFOTW42dm83WURDcU45Y2lNAR6i5Qj2CzmbLvCDWnWB3TWOytvTICiO7xbm_n3IiGAaFBlczM_zvPz9MUygIg_aem_7UbXwqX2v92uAwjCvdYGlw
1 · Reply
Portman62
Portman62 Jul. 22 at 1:21 PM
0 · Reply
History101
History101 Jul. 20 at 7:10 PM
$MESO short interest, per Barron's, 6/30/2025: 2.53MM shares short (down 6% from 6/13/2025) 10.6 days to cover
0 · Reply
topstockalerts
topstockalerts Jul. 18 at 6:11 PM
$MESO buyers are stepping in.. ✅ Keep an eye for upcoming plays
0 · Reply
topstockalerts
topstockalerts Jul. 18 at 5:05 PM
$MESO not a bad place for a swing idea 💡
0 · Reply
topstockalerts
topstockalerts Jul. 18 at 4:27 PM
$MESO primed for continuation.. ✅📈 Stay tuned bulls!!
0 · Reply
TaxiBiotech_
TaxiBiotech_ Jul. 18 at 4:24 PM
$MESO Mesoblast’s Ryoncil® (remestemcel-L) commercial launch recap: First & only FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease $13.2M in Q2 gross sales (Mar 28–Jun 30) $1.6M in royalties from TEMCELL® sales in Japan 🇯🇵 Now covered by Medicare/Medicaid 7-year orphan drug exclusivity + 12-year BLA protection 25 US transplant centers onboarded, targeting 45 🏥 #Biotech #CellTherapy
1 · Reply
ChazzyTrades
ChazzyTrades Jul. 18 at 3:50 PM
$MESO ez money
1 · Reply
Rajankduggy
Rajankduggy Jul. 18 at 3:45 PM
$MESO eyeing up a short on this soon
0 · Reply
Shahr_
Shahr_ Jul. 18 at 2:55 PM
$MESO it’s not even yet on yahoo trend list
0 · Reply
Mani86
Mani86 Jul. 18 at 2:54 PM
$MESO BOOOOOM>>>>>
0 · Reply
f00xy
f00xy Jul. 18 at 2:29 PM
$MESO Analyst target $27 🚀🚀🚀🚀
0 · Reply
f00xy
f00xy Jul. 18 at 2:15 PM
$CAPR $MESO $SRPT 👇👇👇
1 · Reply
Markland55
Markland55 Jul. 18 at 1:41 PM
Symbolic day for biotech Cell therapy company $MESO crosses $SRPT in market cap after successful launch of Ryoncil $CAPR used their CMC journey as a blueprint for their own achievements We are witnessing a tectonic shift that prioritizes safety above all Congrats MESO
2 · Reply
topstockalerts
topstockalerts Jul. 18 at 1:04 PM
$MESO primed for continuation..
0 · Reply